Omnicom Group Inc
Change company Symbol lookup
Select an option...
OMC Omnicom Group Inc
CHDN Churchill Downs Inc
SGTB Kuboo Inc
BBBMX BBH Limited Duration Fund Class N
VICI VICI Properties Inc
DDS Dillard's Inc
ALIN-E Altera Infrastructure LP
AUVGF Australian Vintage Ltd
LQSIF Alcanna Inc
CSX CSX Corp
Go

Communication Services : Media | Mid Cap Value
Company profile

Omnicom Group Inc. is a holding company. The Company provides advertising, marketing and corporate communications services. The Company's branded networks and agencies operate in all markets around the world and provide a range of services, which it groups into four disciplines: advertising, customer relationship management (CRM), public relations and specialty communications. The Company caters to various industry sectors, such as food and beverage, consumer products, pharmaceuticals and healthcare, financial services, technology, travel and entertainment, telecommunications and retail. The Company's branded networks and agencies conduct business on a global basis and operate in the geographic regions, such as The Americas, which includes North America and Latin America; EMEA, which includes Europe, the Middle East and Africa, and Asia Pacific, which includes Australia, China, India, Japan, Korea, New Zealand, Singapore and other Asian countries.

Closing Price
$84.96
Day's Change
0.66 (0.78%)
Bid
--
Ask
--
B/A Size
--
Day's High
85.39
Day's Low
83.60
Volume
(Average)
Volume:
1,593,524

10-day average volume:
1,695,820
1,593,524

Revive Therapeutics Files Business Acquisition Report

5:38 pm ET February 8, 2021 (Globe Newswire) Print

Revive Therapeutics Ltd. ("Revive" or the "Company") (CSE:RVV) (USA: RVVTF), announces that it has filed a Form 51-102F4 Business Acquisition Report (BAR) pursuant to National Instrument 51-102 Continuous Disclosure Obligations in connection with its acquisition of Psilocin Pharma Corp. on March 5, 2020.â?? The BAR has been filed as a result of a review conducted by staff at the Ontario Securities Commission in connection with the Company's recently filed preliminary short form prospectus dated January 26, 2021.

For more information, please contact:

Michael Frank

Chief Executive Officer

Revive Therapeutics Ltd.

Tel: 1 888 901 0036

Email: mfrank@revivethera.com

Website: www.revivethera.com

https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png

https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.